Regeneron tapped for COVID-19 antibody cocktail

Local

RENSSELAER, N.Y. (NEWS10) — The federal government is working to fast track a vaccine and treatment for COVID-19 dubbed Operation Warp Speed, and it’s tapping some of the nation’s best biotech and pharmaceutical companies to try to do it.

In the Capital Region, Regeneron has been awarded a $450 million contract to manufacture and supply a double antibody coronavirus cocktail.

It’s currently in Phase 2 of three clinical trials for treatment of COVID-19, and Phase 3 of trials of the prevention of COVID-19 infection.


Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Coronavirus Videos

Audience sits close at Trump's Mt Rushmore event

Expert: US leaving WHO would be 'gift' to China

Trump: FDA hydroxy warning based on 'phony study'

Kroger to give $130M in ‘Thank You’ pay

Fauci Testifies

Download our news app

App Store Link
Google Play Link
REMARKABLE WOMEN_2022_NOMINATE

Latest PODCAST episode

More PODCAST: On the Story with Trishna Begam
CHECK OUT OUR NEW APP FEATURES